|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 46.65 EUR | +0.34% |
|
-5.54% | +5.87% |
| 07:50am | Berenberg Raises FMC Price Target to 60 Euros, Maintains 'Buy' Rating | DP |
| 07:17am | FMC FRESENIUS MEDICAL CARE AG : Berenberg maintains a Buy rating | ZD |
| Capitalization | 13.64B 15.73B 12.85B 11.67B 21.6B 1,362B 24.34B 152B 58.23B 624B 59.01B 57.75B 2,294B | P/E ratio 2025 * |
14.6x | P/E ratio 2026 * | 11.6x |
|---|---|---|---|---|---|
| Enterprise value | 23.09B 26.62B 21.75B 19.76B 36.56B 2,305B 41.19B 258B 98.55B 1,056B 99.87B 97.74B 3,882B | EV / Sales 2025 * |
1.18x | EV / Sales 2026 * | 1.09x |
| Free-Float |
67.83% | Yield 2025 * |
3.13% | Yield 2026 * | 3.52% |
More valuation ratios
* Estimated data
More news
Last Transcript: Fresenius Medical Care AG
More recommendations
More press releases
More news
| 1 day | +0.37% | ||
| 1 week | -5.54% | ||
| Current month | -6.54% | ||
| 1 month | -8.58% | ||
| 3 months | +3.89% | ||
| 6 months | +7.35% | ||
| Current year | +5.87% |
| 1 week | 45.03 |  | 49.72 |
| 1 month | 45.03 | | 52.58 |
| Current year | 39.43 | | 54.02 |
| 1 year | 32.51 | | 54.02 |
| 3 years | 25.95 | | 54.02 |
| 5 years | 25.95 | | 79.96 |
| 10 years | 25.95 | | 93.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Helen Giza
CEO | Chief Executive Officer | 57 | 05/12/2022 |
Martin Fischer
DFI | Director of Finance/CFO | 48 | 30/09/2023 |
Jörg Häring
CMP | Compliance Officer | 55 | 31/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 58 | 11/05/2016 |
A. Sorensen
BRD | Director/Board Member | 63 | 19/05/2021 |
Michael Sen
CHM | Chairman | 56 | 13/07/2023 |
| Name | Weight | AuM | 1st Jan change | |
|---|---|---|---|---|
| 7.48% | 0 M€ | -.--% | - | |
| 0.8% | 0 M€ | -.--% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.34% | -5.54% | +28.61% | +1.28% | 15.73B | ||
| +0.17% | +1.70% | +11.38% | +113.77% | 90.82B | ||
| -0.40% | -1.32% | +8.47% | -27.08% | 84.21B | ||
| -0.25% | -4.48% | +48.08% | +52.43% | 27.28B | ||
| +1.12% | -0.78% | -15.67% | +29.08% | 23.3B | ||
| +0.19% | +0.29% | +27.59% | +12.27% | 21.92B | ||
| -0.19% | -0.43% | +29.12% | +33.56% | 20.03B | ||
| +0.26% | +2.21% | +25.15% | +209.52% | 15.61B | ||
| -1.33% | -0.85% | +32.07% | +16.31% | 13.94B | ||
| -1.75% | -4.39% | +32.73% | +225.45% | 13.62B | ||
| Average | -0.16% | -1.57% | +22.75% | +66.66% | 32.65B | |
| Weighted average by Cap. | -0.08% | -0.89% | +17.21% | +54.19% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 19.65B 22.65B 18.51B 16.81B 31.11B 1,962B 35.05B 219B 83.86B 899B 84.99B 83.18B 3,303B | 20.3B 23.4B 19.12B 17.37B 32.14B 2,027B 36.21B 226B 86.64B 928B 87.8B 85.93B 3,413B |
| Net income | 928M 1.07B 875M 795M 1.47B 92.7B 1.66B 10.36B 3.96B 42.47B 4.02B 3.93B 156B | 1.16B 1.33B 1.09B 990M 1.83B 116B 2.06B 12.9B 4.94B 52.91B 5B 4.9B 195B |
| Net Debt | 9.45B 10.89B 8.9B 8.08B 14.96B 943B 16.85B 105B 40.32B 432B 40.86B 39.99B 1,588B | 8.52B 9.82B 8.02B 7.29B 13.49B 850B 15.19B 95B 36.36B 390B 36.84B 36.06B 1,432B |
More financial data
* Estimated data
Employees
112,035
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/06/25 | 46.75 € | +0.56% | 86,810 |
| 20/06/25 | 46.49 € | +0.85% | 1,180,918 |
| 19/06/25 | 46.10 € | -1.14% | 445,222 |
| 18/06/25 | 46.63 € | -1.37% | 1,090,541 |
| 17/06/25 | 47.28 € | -4.47% | 1,054,992 |
Delayed Quote Xetra, June 23, 2025 at 12:30 pm
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
17
Last Close Price
46.49EUR
Average target price
51.09EUR
Spread / Average Target
+9.89%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- FME Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition